AppFolio Insider Sold Shares Worth $9,028,779, According to a Recent SEC Filing-July 2024-www.financetom.com

AppFolio Insider Sold Shares Worth $9,028,779, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

AppFolio Insider Sold Shares Worth $9,028,779, According to a Recent SEC Filing

Jun 14, 2024 1:03 AM

03:34 AM EDT, 06/14/2024 (MT Newswires) -- Timothy K Bliss, Director, on June 11, 2024, sold 38,270 shares in AppFolio ( APPF ) for $9,028,779.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1433195/000095017024073243/xslF345X03/ownership.xml

Previous page： DSV ahead in bidding for Deutsche Bahn's Schenker, sources say Next page： Y-mAbs Therapeutics' Neuroblastoma Drug Shows Consistent Disease Control in Clinical Study

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DSV ahead in bidding for Deutsche Bahn's Schenker, sources say

Sep 6, 2024

BERLIN (Reuters) - Danish transport firm DSV is slightly ahead in the bidding race for German state railway Deutsche Bahn's logistics unit Schenker, several people familiar with the sales process told Reuters on Friday. DSV's offer is currently seen as the most attractive, the sources said after a meeting of a government committee that evaluated the bid along with a...

Y-mAbs Therapeutics' Neuroblastoma Drug Shows Consistent Disease Control in Clinical Study

Sep 6, 2024

09:24 AM EDT, 09/06/2024 (MT Newswires) -- Y-mAbs Therapeutics ( YMAB ) reported Friday that its cancer drug naxitamab demonstrated consistent disease control in refractory or relapsed high-risk, or hard-to-treat neuroblastoma cancer patients. The company said naxitamab, combined with granulocyte-macrophage colony-stimulating factor, achieved a 63% disease control rate in patients with refractory or relapsed high-risk neuroblastoma, regardless of their baseline...

--Biden Enmity to US Steel-Nippon Steel Deal 'Very Unsettling,' Japan PM Hopeful Tells Reuters

Sep 6, 2024

07:59 AM EDT, 09/06/2024 (MT Newswires) -- Price: 30.82, Change: +0.85, Percent Change: +2.84 ...

Ski-Doo And Lynx Snowmobiles Maker BRP Slashes FY25 Outlook As Sales Plunge Across All Product Lines: Details

Sep 6, 2024

BRP Inc. ( DOOO ) shares are trading lower in Friday’s premarket session after the company reported second-quarter results and revised its FY25 guidance downward. The company reported second-quarter adjusted EPS of C$0.61, a decrease of C$2.60 per share from the year-ago quarter. In USD, adjusted EPS was $0.45 above the consensus of $0.33. BRP reported quarterly revenues decrease of 33.7% year-over-year...